RPID
RAPID MICRO BIOSYSTEMS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$0.77
+1.20%Year over year
Reported trailing growth
- Revenue
- +16.1%
- EBITDA
- -8.4%
- EBIT
- -8.0%
- EPS
- -9.9%
- Free cash flow
- -5.5%
- Operating cash flow
- -7.5%
Forward estimates
Based on analyst estimates
- Revenue
- +25.8%
- EBITDA
- +41.1%
- EPS
- +36.9%
Three-year CAGR
- Revenue
- +25.2%
- EBITDA
- +1.8%
- EBIT
- +5.1%
- Net income
- -0.5%
- EPS
- +2.8%
- Free cash flow
- +29.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026